Skip to main content
https://pbs.twimg.com/media/Ft8CcTPXoAA6dpS.jpg
The European Commission has approved upadacitinib (Rinvoq) for the Treatment of Moderately to Severely Active Crohn's Disease https://t.co/Clzca7jU5b https://t.co/nNFGe5fF25
Dr. John Cush
17-04-2023
×